NFE2L2 and cancer: Taken together, these data have indicated that targeting the NRF2-dependent regulation of iron metabolism might be a valid strategy to combat chemoresistance and induce ferroptosis in a variety of malignant tumors, especially in those forms that are refractory to apoptosis inducers by virtue of intrinsic or acquired resistance caused by defects in the apoptotic machinery.